Viewing nowCombinationTapagins Plus Sustained-release Tablet 10/500 mg
Metformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
DaeHwa Pharmaceutical Co., Ltd.

MFDS item code 202300229 · Approved 2023.01.12 · Insurance code 645605770
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to help control blood sugar in adults with Type 2 diabetes who are taking dapagliflozin and metformin together. It is administered as an adjunct to dietary and exercise regimens to improve blood sugar levels. Caution is advised for patients with Type 2 diabetes who do not have adequate blood sugar control and have cardiovascular disease or risk factors, and detailed information can be found in professional clinical trial documents. Overall, this medication helps improve blood sugar control and effectively manage Type 2 diabetes.
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, given as 2 tablets of 5mg/1000mg. Patients who have not previously received antidiabetic drug therapy and whose blood glucose is not adequately controlled with monotherapy: When used as initial therapy in patients who have not previously received antidiabetic drug therapy, the recommended starting dose of this medicine is 1 tablet of 5mg/500mg or 10mg/500mg once daily. Titrate the dose gradually to reduce gastrointestinal adverse effects of metformin. For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this medicine should provide the patient's current metformin dose or an appropriately titrated dose therapeutically equivalent to it. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted appropriately. For patients switching from concomitant dapagliflozin and metformin therapy to this medicine, the dose of this medicine may be initiated at the doses of dapagliflozin and metformin previously administered. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted appropriately. When this medicine is used concomitantly with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other antihyperglycemic agents. Because such a change may result in changes in glycemic control, any change in treatment in patients with type 2 diabetes should be made under close monitoring. This medicine must be swallowed whole and must never be crushed, cut, or chewed. Occasionally, the inactive ingredients of this medicine may be excreted in the stool as a soft, hydrated mass resembling a tablet. Renal impairment No dose adjustment is required for patients with mild renal impairment. For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or greater and less than 60 mL/min/1.73 m2, who do not have other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medicine is not recommended in patients with an eGFR of less than 45 mL/min/1.73m2. If the eGFR falls below 45 mL/min/1.73m2, this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months. Older adults Metformin is excreted by the kidneys, and older adults are more likely to have decreased renal function; therefore, this medicine should be used with caution as age increases (see Precautions for Use, 9. Administration to Older Adults).
This medication helps lower blood sugar. However, there are several precautions to take when using this medication. Firstly, this medication should not be used in patients with impaired kidney function. In cases of moderate or severe kidney impairment, this medication may accumulate in the body and pose risks. Patients who are dehydrated or have severe infections, heart issues, or acute myocardial infarction should also avoid this medication, as these conditions heighten the risk of side effects. Pregnant or breastfeeding women should not use this medication, nor should patients with certain genetic issues such as lactose intolerance. This medication may cause hypoglycemia when used with other diabetes treatments, so dosage adjustments are necessary when used in conjunction with insulin or sulfonylureas. While taking this medication, genital or urinary infections may occur, so immediate consultation with a physician is warranted if such symptoms arise. Additionally, this medication may cause decreased fluid volume or hypotension, so elderly patients or those taking diuretics should regularly check their blood pressure and fluid status. Due to the metformin component, rare but severe side effects such as lactic acidosis may occur, so if symptoms like fatigue, muscle pain, difficulty breathing, or abdominal pain occur, immediate communication with healthcare personnel is critical. It is safer for patients with liver or kidney impairment to avoid this medication. Regular assessments of kidney function should be conducted before and during the course of this medication, especially for older adults. Furthermore, it is dangerous to consume alcohol while taking this medication, so excessive drinking should be avoided. This medication should be temporarily discontinued when undergoing surgery or radiographic examinations with contrast agents and resumed only after confirming normal kidney function post-examination. In case of an overdose, immediate visit to a healthcare facility for appropriate treatment is necessary, and dialysis may be beneficial if required. Lastly, this medication has not established safety and effectiveness in children; therefore, it should not be used in this population. Caution is warranted while driving or operating machinery, as dizziness may occur during medication use. Keep this medication out of reach of children and store it in its original container.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to avoid exposure to air or moisture, at room temperature between 1 and 30 degrees Celsius. This storage method helps maintain the medication’s effectiveness and safety.
Pink, double convex, rectangular sustained-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
DaeHwa Pharmaceutical Co., Ltd.
Metformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
Metformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
YouYoung Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Yuyoung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.